Ayme Rodriguez
Psychiatric/Mental Health · Doral, FLNPI 1538823422
Payments from drug & device makers
Across 218 payments — averaging $24.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$1K
- Axsome Therapeutics, Inc.$800
- Johnson & Johnson$585
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$536
- Lundbeck LLC$408
- AbbVie$321
- plus $2K from 15 others
What the payments were for
- Food & beverage$5,247100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 43 | $1,040 |
| Axsome Therapeutics, Inc. | 36 | $800 |
| Johnson & Johnson | 17 | $585 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $536 |
| Lundbeck LLC | 18 | $408 |
| AbbVie | 15 | $321 |
| Vanda Pharmaceuticals Inc. | 11 | $305 |
| Alkermes, Inc. | 12 | $236 |
| Idorsia Pharmaceuticals US Inc | 6 | $216 |
| Almatica Pharma LLC | 8 | $201 |
| Otsuka America Pharmaceutical, Inc. | 6 | $140 |
| E.r. Squibb & Sons, L.L.C. | 4 | $97 |
| Collegium Pharmaceutical, Inc. | 4 | $83 |
| Biogen | 3 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Tempus AI, Inc | 2 | $43 |
| Ironshore Pharmaceuticals Inc. | 2 | $37 |
| Neos Therapeutics, LP | 2 | $32 |
| Sage Therapeutics, LLC | 1 | $19 |
| Livanova USA, Inc. | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,247 in reported general payments places this provider in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $869 |
| Atomoxetine Hcl | 11 | $403 |
| Paroxetine Hcl | 20 | $148 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 11 | $130 |
| Bupropion XlBupropion Hcl | 13 | $119 |
| Clonazepam | 21 | $82 |
| Lamotrigine | 12 | $77 |
| Trazodone Hcl | 13 | $53 |
| Citalopram HbrCitalopram Hydrobromide | 12 | $48 |
| Buspirone Hcl | 12 | $39 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Doral
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.